Evidence map›Paper›PMID 10768950›Full record

ArticleInfection and immunity2000

Evaluation of an isogenic major outer membrane protein-deficient mutant in the human model of Haemophilus ducreyi infection.

R E Throm, J A Al-Tawfiq, K R Fortney, B P Katz, A F Hood, C A Slaughter, E J Hansen, S M Spinola

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Molecular pathogenesis ofMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  2. Article
  3. Interactions of the Skin PathogenFrontiers in immunology · 2020
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

R E ThromDepartment of Microbiology and Immunology, School of Medicine, Indiana University, Indianapolis, Indiana 46202, USA.
J A Al-Tawfiq
K R Fortney
B P Katz
A F Hood
C A Slaughter
E J Hansen
S M Spinola
Bipar · FRIndiana University – Purdue University Indianapolis · USThe University of Texas Southwestern Medical Center · US

Funding

ZOSUQUIDAR TRIHYDROCHLORIDE DURING CONVENTIONAL INDUCTION AND POST-REMISSIONM01RR000750 · NCRR · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI PEACOCK, MUNRO · 1985 to 2008
$25.5M
VIRAL DETERMINANTS OF HSV DISEASE IN MICEU19AI031494 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI LAIMINS, LAIMONIS A. · 1995 to 2009
$13.6M
Haemophilus ducreyi Inhibits PhagocytosisR37AI032011 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI HANSEN, ERIC JOHN · 2006 to 2015
$3.8M
PATHOGENESIS OF HAEMOPHILUS DUCREYI INFECTIONSR01AI027863 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SPINOLA, STANLEY M. · 1995 to 2013
$3.8M
MOLECULAR PATHOGENESIS OF CHANCROIDR01AI032011 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI HANSEN, ERIC JOHN · 1992 to 2004
$1.7M
Haemophilus ducreyi Inhibits PhagocytosisR56AI032011 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI HANSEN, ERIC JOHN · 2005 to 2005
$390k
SEXUALLY TRANSMITTED DISEASES CLINICAL TRIALS UNITN01AI075329 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · 1997 to 2003
$346k
PATHOGENESIS OF HAEMOPHILUS DUCREYI INFECTIONSR29AI027863 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SPINOLA, STANLEY M · 1990 to 1994
–
VARIABILITY IN HERPES SIMPLEX VIRUS GLYCOPROTEINS AND INFECTIVITYU01AI031494 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI JONES, ROBERT B · 1991 to 1994
–
NCRR NIH HHS M01 RR000750NIAID NIH HHS AI27863NIAID NIH HHS AI31494NIAID NIH HHS AI32011NIAID NIH HHS N01 AI075329NIAID NIH HHS R01 AI027863NIAID NIH HHS R01 AI032011NIAID NIH HHS R37 AI032011NIAID NIH HHS R56 AI032011NIAID NIH HHS U19 AI031494
6 · The paper itself

Abstract

Haemophilus ducreyi expresses 2 OmpA homologs, designated MOMP and OmpA2, whose genes are arranged in tandem on the chromosome. Northern blot analysis indicated that momp and ompA2 are transcribed independently. Sequences of the momp open reading frame (ORF) lacking the transcriptional start site were amplified by PCR, and an Omega-Km2 cassette was ligated into the ORF. A plasmid containing this construction was electroporated into H. ducreyi 35000HP, and an isogenic MOMP-deficient mutant (35000HP-SMS2) was generated by allele exchange. In Southern blotting, 35000HP-SMS2 contained one copy of the Omega-Km2 cassette in momp. 35000HP and 35000HP-SMS2 had similar outer membrane protein (OMP) and lipooligosaccharide profiles and growth rates except for up-regulation of a putative porin protein in the mutant. Five subjects were inoculated with three doses of live 35000HP-SMS2 on one arm and two doses of live 35000HP and one dose of a heat-killed control on the other arm in a double-blind escalating dose-response trial. Pustules developed at 7 of 10 sites inoculated with 35000HP and at 6 of 15 sites inoculated with 35000HP-SMS2 (P = 0.14). 35000HP and 35000HP-SMS2 were recovered at similar rates from daily surface cultures and semiquantitative cultures. The data suggest that expression of MOMP is not required for pustule formation by H. ducreyi in the human model of infection.

Indexed as

AdultAmino Acid SequenceBacterial Outer Membrane ProteinsChancroidFemaleGene DeletionHaemophilus ducreyiHumansModels, BiologicalMolecular Sequence DataPhenotypeTranscription, GeneticBacterial Outer Membrane Proteinsmajor outer membrane protein, HaemophilusOmpA2 protein, Haemophilus decreyi

Identifiers

PMID10768950
PMCPMC97465
OpenAlexW2121082604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.